24083638|t|Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration.
24083638|a|BACKGROUND: Posttranslational modifications of beta amyloid (Abeta) have been shown to affect its biophysical and neurophysiological properties. One of these modifications is N-terminal pyroglutamate (pE) formation. Enzymatic glutaminyl cyclase (QC) activity catalyzes cyclization of truncated Abeta(3-x), generating pE3-Abeta. Compared to unmodified Abeta, pE3-Abeta is more hydrophobic and neurotoxic. In addition, it accelerates aggregation of other Abeta species. To directly investigate pE3-Abeta formation and toxicity in vivo, transgenic (tg) ETNA (E at the truncated N-terminus of Abeta) mice expressing truncated human Abeta(3-42) were generated and comprehensively characterized. To further investigate the role of QC in pE3-Abeta formation in vivo, ETNA mice were intercrossed with tg mice overexpressing human QC (hQC) to generate double tg ETNA-hQC mice. RESULTS: Expression of truncated Abeta(3-42) was detected mainly in the lateral striatum of ETNA mice, leading to progressive accumulation of pE3-Abeta. This ultimately resulted in astrocytosis, loss of DARPP-32 immunoreactivity, and neuronal loss at the sites of pE3-Abeta formation. Neuropathology in ETNA mice was associated with behavioral alterations. In particular, hyperactivity and impaired acoustic sensorimotor gating were detected. Double tg ETNA-hQC mice showed similar Abeta levels and expression sites, while pE3-Abeta were significantly increased, entailing increased astrocytosis and neuronal loss. CONCLUSIONS: ETNA and ETNA-hQC mice represent novel mouse models for QC-mediated toxicity of truncated and pE-modified Abeta. Due to their significant striatal neurodegeneration these mice can also be used for analysis of striatal regulation of basal locomotor activity and sensorimotor gating, and possibly for DARPP-32-dependent neurophysiology and neuropathology. The spatio-temporal correlation of pE3-Abeta and neuropathology strongly argues for an important role of this Abeta species in neurodegenerative processes in these models.
24083638	0	18	Glutaminyl cyclase	Gene	70536
24083638	28	36	toxicity	Disease	MESH:D064420
24083638	40	66	pyroglutamate-beta amyloid	Chemical	-
24083638	84	101	neurodegeneration	Disease	MESH:D019636
24083638	164	169	Abeta	Gene	11820
24083638	278	302	N-terminal pyroglutamate	Chemical	-
24083638	304	306	pE	Chemical	MESH:D011761
24083638	329	347	glutaminyl cyclase	Gene	25797
24083638	397	402	Abeta	Gene	351
24083638	420	423	pE3	CellLine	CVCL:6D81
24083638	424	429	Abeta	Gene	351
24083638	454	459	Abeta	Gene	351
24083638	465	470	Abeta	Gene	351
24083638	495	505	neurotoxic	Disease	MESH:D020258
24083638	556	561	Abeta	Gene	351
24083638	599	604	Abeta	Gene	351
24083638	619	627	toxicity	Disease	MESH:D064420
24083638	692	697	Abeta	Gene	11820
24083638	699	703	mice	Species	10090
24083638	725	730	human	Species	9606
24083638	731	742	Abeta(3-42)	Gene	351
24083638	838	843	Abeta	Gene	351
24083638	863	867	ETNA	Chemical	-
24083638	868	872	mice	Species	10090
24083638	899	903	mice	Species	10090
24083638	919	924	human	Species	9606
24083638	956	960	ETNA	Chemical	-
24083638	965	969	mice	Species	10090
24083638	1004	1015	Abeta(3-42)	Gene	351
24083638	1063	1067	ETNA	Chemical	-
24083638	1068	1072	mice	Species	10090
24083638	1117	1122	Abeta	Gene	11820
24083638	1152	1164	astrocytosis	Disease	MESH:D005911
24083638	1174	1182	DARPP-32	Gene	19049
24083638	1205	1218	neuronal loss	Disease	MESH:D009410
24083638	1239	1244	Abeta	Gene	11820
24083638	1279	1283	mice	Species	10090
24083638	1343	1356	hyperactivity	Disease	MESH:D006948
24083638	1361	1398	impaired acoustic sensorimotor gating	Disease	MESH:D020233
24083638	1433	1437	mice	Species	10090
24083638	1453	1458	Abeta	Gene	11820
24083638	1498	1503	Abeta	Gene	11820
24083638	1554	1566	astrocytosis	Disease	MESH:D005911
24083638	1571	1584	neuronal loss	Disease	MESH:D009410
24083638	1599	1603	ETNA	Chemical	-
24083638	1608	1612	ETNA	Chemical	-
24083638	1617	1621	mice	Species	10090
24083638	1638	1643	mouse	Species	10090
24083638	1667	1675	toxicity	Disease	MESH:D064420
24083638	1693	1695	pE	Chemical	MESH:D011761
24083638	1705	1710	Abeta	Gene	351
24083638	1746	1763	neurodegeneration	Disease	MESH:D019636
24083638	1770	1774	mice	Species	10090
24083638	1898	1906	DARPP-32	Gene	19049
24083638	1992	1997	Abeta	Gene	11820
24083638	2063	2068	Abeta	Gene	11820
24083638	Positive_Correlation	MESH:D009410	11820
24083638	Association	MESH:D011761	351
24083638	Positive_Correlation	MESH:D005911	11820
24083638	Bind	11820	351
24083638	Association	MESH:D020258	351
24083638	Positive_Correlation	MESH:D009410	351
24083638	Association	25797	351
24083638	Association	MESH:D019636	70536
24083638	Association	MESH:D064420	70536
24083638	Association	MESH:D020233	11820

